These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6243862)

  • 1. Comparative study of high-dose chorionic gonadotropin on the human and rat corpus luteum and effect of gonadotropin-releasing hormone on human luteal function.
    Caldwell BV; Rotchell YE; Pang CY; Anderson GG; Kase N; Behrman HR
    Am J Obstet Gynecol; 1980 Feb; 136(4):458-64. PubMed ID: 6243862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
    VandeVoort CA; Hess DL; Stouffer RL
    Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-sensitive progesterone production by rhesus monkey luteal cells in vitro: a function of age of the corpus luteum during the menstrual cycle.
    Stouffer RL; Nixon WE; Gulyas BJ; Hodgen GD
    Endocrinology; 1977 Feb; 100(2):506-12. PubMed ID: 401732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
    Lemay A; Faure N; Labrie F
    Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced LH sensitivity in vivo and in vitro of corpora lutea induced during anoestrus by GnRH, and during the late breeding season, in Scottish Blackface ewes.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    J Endocrinol; 2004 Dec; 183(3):517-26. PubMed ID: 15590978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of exogenous human chorionic gonadotrophin on progesterone production from normal or malfunctioning corpus luteum.
    Momoeda M; Tsutsumi O; Morita Y; Igarashi T; Suenaga A; Osuga Y; Shiotsu H; Yano T; Taketani Y
    Hum Reprod; 1998 Jul; 13(7):1907-11. PubMed ID: 9740447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma estrogen, luteinizing hormone, follicle-stimulating hormone and 13,14-dihydro-15-keto-prostaglandin F2 alpha during blockade of luteolysis in pigs after human chorionic gonadotropin treatment.
    Guthrie HD; Bolt DJ
    J Anim Sci; 1983 Oct; 57(4):993-1000. PubMed ID: 6417098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroidogenic responsiveness of the monkey corpus luteum to exogenous chorionic gonadotropin.
    Wilks JW; Noble AS
    Endocrinology; 1983 Apr; 112(4):1256-66. PubMed ID: 6832045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
    Ottobre JS; Stouffer RL
    Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
    Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
    J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pretreating heifers with human chorionic gonadotropin and estradiol on subsequent in vitro luteal tissue progesterone biosynthesis.
    Moody EL; Hansel W
    J Anim Sci; 1971 Nov; 33(5):1032-7. PubMed ID: 5119969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.